Patients with Coffin-Siris Syndrome 3 often present with a combination of physical and developmental symptoms. Common features include:

• Developmental Delays: Delays in reaching milestones such as sitting, walking, and talking.
• Intellectual Disability: Ranging from mild to severe.
• Distinctive Facial Features: These may include a wide mouth, thick eyebrows, long eyelashes, and a flat nasal bridge.
• Hypotonia: Reduced muscle tone, which can affect motor skills.
• Fifth Finger Abnormalities: Underdeveloped or absent nails on the fifth fingers or toes.

Additional symptoms may include feeding difficulties, frequent respiratory infections, and behavioral issues.

Diagnosing CSS3 involves a combination of clinical evaluation and genetic testing. The workup typically includes:

• Clinical Assessment: A thorough examination of physical features and developmental history.
• Genetic Testing: Sequencing of the SMARCB1 gene to identify mutations.
• Imaging Studies: MRI or CT scans may be used to assess brain structure and rule out other conditions.
• Developmental Assessments: Evaluations by specialists to determine the extent of developmental delays and intellectual disability.

There is no cure for Coffin-Siris Syndrome 3, but treatment focuses on managing symptoms and supporting development. This may include:

• Early Intervention: Speech, occupational, and physical therapy to address developmental delays.
• Educational Support: Special education programs tailored to the child's needs.
• Medical Management: Treatment of associated health issues such as respiratory infections or feeding difficulties.
• Behavioral Therapy: To address any behavioral challenges.

The prognosis for individuals with CSS3 varies depending on the severity of symptoms. With appropriate support and interventions, many individuals can achieve a good quality of life. However, intellectual disability and developmental delays are typically lifelong challenges.

Coffin-Siris Syndrome 3 is caused by mutations in the SMARCB1 gene. This gene is part of a group that regulates chromatin remodeling, which is essential for normal development and gene expression. Mutations in SMARCB1 disrupt these processes, leading to the symptoms observed in CSS3.

CSS3 is an extremely rare condition, with only a limited number of cases reported worldwide. It affects both males and females and does not appear to be linked to any specific ethnic or geographic population.

The SMARCB1 gene encodes a protein that is part of the SWI/SNF complex, which is involved in chromatin remodeling. This complex helps regulate the accessibility of DNA for transcription, a process necessary for normal cellular function and development. Mutations in SMARCB1 impair this function, leading to the developmental and physical abnormalities seen in CSS3.

As a genetic disorder, there is no known way to prevent Coffin-Siris Syndrome 3. Genetic counseling may be beneficial for families with a history of the condition to understand the risks and implications for future pregnancies.

Coffin-Siris Syndrome 3 is a rare genetic disorder caused by mutations in the SMARCB1 gene. It is characterized by developmental delays, intellectual disability, and distinctive physical features. While there is no cure, early intervention and supportive therapies can help manage symptoms and improve quality of life. Genetic testing is essential for diagnosis, and ongoing research aims to better understand and treat this condition.

For patients and families affected by Coffin-Siris Syndrome 3, understanding the condition is crucial. CSS3 is a genetic disorder that affects development and physical appearance. It is important to work closely with healthcare providers to create a comprehensive care plan that includes therapies and educational support. While the condition presents challenges, many individuals with CSS3 can lead fulfilling lives with the right support and interventions.